title: Effect of losartan on plasma C-reactive protein in type 2 diabetic patients with microabluminuria.
authors.forename: Kathryn
authors.initials: K
authors.lastname: Tan
authors.forename: Wing-Sun
authors.initials: WS
authors.lastname: Chow
authors.forename: Ying
authors.initials: Y
authors.lastname: Wong
authors.forename: Sammy
authors.initials: S
authors.lastname: Shiu
authors.forename: Sidney
authors.initials: S
authors.lastname: Tam
mesh_terms: D000419:Albuminuria / Q000188:drug therapy*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000037:antagonists & inhibitors / Q000187:drug effects / Q000378:metabolism*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003928:Diabetic Nephropathies / Q000188:drug therapy; D005260:Female; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008297:Male; D012016:Reference Values
chemical_list: D000959:Antihypertensive Agents; D002097:C-Reactive Protein; D019808:Losartan